Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microvasculopathy in spinal muscular atrophy is driven by a reversible autonomous endothelial cell defect. | J Clin Invest | 2022 | 36099045 | PubTator, text mining | PubMed |
| Mouse models of SMA show divergent patterns of neuronal vulnerability and resilience. | Skelet Muscle | 2022 | 36089582 | PubTator, text mining | PubMed |
| Long-read sequencing for molecular diagnostics in constitutional genetic disorders. | Hum Mutat | 2022 | 36086952 | PubTator, text mining | PubMed |
| Optimization of Bifunctional Antisense Oligonucleotides for Regulation of Mutually Exclusive Alternative Splicing of PKM Gene. | Molecules | 2022 | 36080449 | PubTator, text mining | PubMed |
| The Proteome Signatures of Fibroblasts from Patients with Severe, Intermediate and Mild Spinal Muscular Atrophy Show Limited Overlap. | Cells | 2022 | 36078032 | PubTator, text mining | PubMed |
| Development of the Method for Nusinersen and Its Metabolites Identification in the Serum Samples of Children Treated with Spinraza for Spinal Muscular Atrophy. | Int J Mol Sci | 2022 | 36077568 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals dysregulation of spinal cord cell types in a severe spinal muscular atrophy mouse model. | PLoS Genet | 2022 | 36074806 | PubTator, text mining | PubMed |
| Investigation on the Effects of Modifying Genes on the Spinal Muscular Atrophy Phenotype. | Glob Med Genet | 2022 | 36071912 | PubTator, text mining | PubMed |
| Alkyne Activation in the Diversity Oriented Synthesis of sp2 -Rich Scaffolds: A Biased Library Approach for Targeting Polynucleotides (DNA/RNA). | Chemistry | 2022 | 36069042 | PubTator, text mining | PubMed |
| Spinal muscular atrophy carrier frequency in Saudi Arabia. | Mol Genet Genomic Med | 2022 | 36062320 | PubTator, text mining | PubMed |
| [Update on spinal muscular atrophy treatment]. | Medicina (B Aires) | 2022 | 36054863 | PubTator, text mining | PubMed |
| [Combination of modifying therapies in type 2 spinal muscular atrophy]. | Rev Med Inst Mex Seguro Soc | 2022 | 36049072 | PubTator, text mining | PubMed |
| Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy. | Eur J Neurol | 2022 | 36047967 | PubTator, text mining | PubMed |
| CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics. | Neurotox Res | 2022 | 36044181 | PubTator, text mining | PubMed |
| Respiratory muscle fatigability in patients with spinal muscular atrophy. | Pediatr Pulmonol | 2022 | 36039838 | PubTator, text mining | PubMed |
| Identification of a cytokine profile in serum and cerebrospinal fluid of pediatric and adult spinal muscular atrophy patients and its modulation upon nusinersen treatment. | Front Cell Neurosci | 2022 | 36035258 | PubTator, text mining | PubMed |
| History of development of the life-saving drug "Nusinersen" in spinal muscular atrophy. | Front Cell Neurosci | 2022 | 36035257 | PubTator, text mining | PubMed |
| A review on the role of miRNA-324 in various diseases. | Front Genet | 2022 | 36035118 | PubTator, text mining | PubMed |
| Translational potential of base-editing tools for gene therapy of monogenic diseases. | Front Bioeng Biotechnol | 2022 | 36032737 | PubTator, text mining | PubMed |
| Investigating attitudes toward prenatal diagnosis and fetal therapy for spinal muscular atrophy. | Prenat Diagn | 2022 | 36029101 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=43